Nipah monoclonal antibody trials may begin in India in 2025 Subject: Science and tech Sec: Health Context: The Indian drug regulator greenlights it, a human clinical trial to test the safety and efficacy of a novel Nipah monoclonal antibody MBP1F5, which might offer immediate protection to people at risk of infection against the […]